About This Event
Obsessive-compulsive disorder affects 1 person in 40, but is often undiagnosed or improperly treated. Even with optimal treatment, a third of OCD sufferers do not improve significantly; remission of moderate to severe disease is uncommon. Dr. Pittenger will discuss two new investigational approaches: one using low-voltage non-invasive brain stimulation and the other harnessing the exciting new strategy of fMRI-driven neurofeedback.
Christopher Pittenger, M.D., Ph.D.
Yale School of Medicine
Director, Yale OCD Research Clinic
Co-Director, Neuroscience Research Training Program
2015 Independent Investigator Grant
2009 Young Investigator Grant
2007 Young Investigator Grant